ULCERATIVE COLITIS COMPLICATED BY COLOCUTANEUS FISTULA: A CASE STUDY
Abstract
Background. Ulcerative colitis (UC) is a multifactorial chronic inflammatory bowel disease characterized by such symptoms as abdominal pain, diarrhea, and rectal bleeding. One of the complications of UC is the formation of fistulas with the bladder, vagina, perineum, and other structures. Objective. To present a clinical case of ulcerative colitis complicated by colocutaneous fistula. Material and Methods. Clinical observation data of a 68-year-old man having been treated in the Purulent Surgery Department of the Grodno University Clinic. Results. The patient, with a low body mass index (17.1 kg/m²), was admitted for leakage of intestinal contents from postoperative scar (with a history of a midline laparotomy for intestinal obstruction with creation of a loop ileostomy). Imaging confirmed a fistula to the sigmoid colon, and colonoscopy revealed erosive proctosigmoiditis. A left-sided hemicolectomy was performed. Histological findings were consistent with ulcerative colitis. Postoperatively, an abdominal abscess developed, which was successfully treated with drainage. Conclusion. The case illustrates the complexities of UC management and its multifactorial nature.
References
Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmunity Reviews. 2014;13(4-5):463-466. https://doi.org/10.1016/j.autrev.2014.01.028.
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756-70. https://doi.org/10.1016/S0140-6736(16)32126-2.
Jelinsky S, Lee I, Monetti M, Breitkopf S, Martz F, Kongala R, Culver J, Vo V, Xue L, Gieseck R, Dickinson C, Kasaian M, Lord JD. Proteomic Differences in Colonic Epithelial Cells in Ulcerative Colitis Have an Epigenetic Basis. Gastro Hep Advances. 2024;3(6):830-841. https://doi.org/10.1016/j.gastha.2024.04.014.
Eberspacher C, Mascagni D, Fralleone L, Maturo A, Di Matteo FM, De Cristofaro F, Merletti D, Santoro A, Mascagni P, Pontone S, Pironi D. Colocutaneous fistula through ulcerative colitis and cancer to the pyoderma gangrenosum: a never-ending story for a single patient. Case report. Giornale di chirurgia. 2019;40(1):39-43.
Iglay K, Bennett D, Kappelman MD, Thai S, Aldridge M, Karki C, Cook SF. A systematic review of the patient burden of Crohn’s disease-related rectovaginal and anovaginal fistulas. BMC Gastroenterology. 2022;22(1):36. https://doi.org/10.1186/s12876-021-02079-8.
Shen B. Endoscopic Therapy of Fistulas from Chronic Anastomotic Leaks. In: Shen B, Kiran RP, editors. Corrective Endoscopy and Surgery in Inflammatory Bowel and Colorectal Diseases. London: Elsevier; 2025. р. 243-52. https://doi.org/10.1016/B978-0-323-83439-1.00017-2.
Kumar BS, Sharath PB. Management of Colocutaneous Fistula with Surgical Intervention: A Case Report. Journal of Clinical and Diagnostic Research. 2023;17(5):1-3. https://doi.org/10.7860/JCDR/2023/54842.17906.
Mei Z, Du P, Han Y, Qu Y, Tang H, Li Y, Gao H, Wang Q, Zheng D. Risk factors for delayed wound healing after anal fistula surgery: Protocol of a meta-analytic study. PLoS One. 2025;20(7):e0329030. https://doi.org/10.1371/journal.pone.0329030.
Aggarwal A, Atreja A, Kapadia S, Lopez R, Achkar JP. Conventional Risk Factors and Cardiovascular Outcomes of Patients with Inflammatory Bowel Disease with Confirmed Coronary Artery Disease. Inflammatory Bowel Diseases. 2014;20(9):1593-1601. https://doi.org/10.1097/MIB.0000000000000109.
Ikeda A, Mizushima T, Egashira Y, Takahashi H, Miyoshi N, Haraguchi N, Hata T, Matsuda C, Doki Y, Mori M. Diverticular colitis with progression to ulcerative colitis after sigmoidectomy. Clin J Gastroenterol. 2018;11(1):42-47. https://doi.org/10.1007/s12328-017-0801-9.
Gül F, Tekin E, Çankaya E, Sabaz MS, Çiloğlu Iİ, Oktay BD, Schneideret AG. Clinical efficacy of a protocol-based hemoadsorption therapy in patients with septic shock. Turkish Journal of Intensive Care. 2026;24(1):49-62. https://doi.org/10.63729/TJIC.2025.679.
Kogelmann K, Scheller M, Drüner M, Jarczak D. Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: A case series. Journal of the Intensive Care Society. 2020;21(2):183-90. https://doi.org/10.1177/1751143718818992.
Yakubtsevich RE, Rakashevich DN, Pratasevich PP, Neuhen IN. Ispolzovanie anticitokinovyh svojstv otechestvennogo gemosorbenta "Gemo-proteazosorb" pri "citokinovom shtorme" u pacientov s tjazhelym techeniem COVID-19 [The use of anti-cytokine properties of the domestic hemosorbent hemo-proteasosorb in cytokine storm in patients with severe COVID-19]. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of the Grodno State Medical University]. 2021;19(2):159-165. https://doi.org/10.25298/2221-8785-2021-19-2-159-165. https://www.elibrary.ru/qeicwp. (Russian).
Belyavsky NV, Yakubtsevich RE, Kurbat MN. Izmenenie koncentracii v plazme meropenema na fone provedenija jekstrakorporalnoj gemoperfuzii cherez selektivnye gemosorbenty u pacientov s sepsisom pri provedenii kompleksnoj intensivnoj terapii [Meropenem plasma levels changes during extracorporeal hemoperfusion through selective hemosorbents in patients with sepsis under complex intensive therapy]. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of the Grodno State Medical University]. 2022;20(3):330-334. https://doi.org/10.25298/2221-8785-2022-20-3-330-334. https://www.elibrary.ru/nnmvqa. (Russian).
Sudhir U, Venkatachalaiah RK, Kumar TA, Rao MY, Kempegowda P. Significance of serum procalcitonin in sepsis. Indian Journal of Critical Care Medicine. 2011;15(1):1-5. https://doi.org/10.4103/0972-5229.78214.
1.png)
